Reagents are required to perform blood testing for BMT mission.

Ended Awarded Last action

Contract number
HT009026FG30032
Awardee
Awarding agency
Obligated
$81,877

Award facts

Contract value 100% obligated
$81,876.89 Current and potential, with all options
Completion date
Current and potential, with all options
NAICS code
325413 In-Vitro Diagnostic Substance Manufacturing
PSC
6550 In Vitro Diagnostic Substances, Reagents, Test Kits And Sets
Set-aside
No set-aside
Competition
Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
North Chicago, IL 60064, USA

Award details come from SAM.gov/FPDS.

About this award

The Defense Health Agency issued a BPA call to Abbott Laboratories Inc. (Abbott Diagnostics Division) on February 14, 2026, with a ceiling value of $81,876.89 for blood-testing reagents required to support the BMT (bone marrow transplant) mission. Place of performance is North Chicago, Illinois. The call is firm fixed price with an ultimate completion date of February 14, 2026 and was issued under no set-aside. The source does not identify the parent BPA by name or specify a period of performance distinct from the completion date.

Quick answers

Who was awarded contract HT009026FG30032?

HT009026FG30032 was awarded to Abbott Laboratories Inc. by Defense Health Agency (Department of Defense) on February 14, 2026.

How much is contract HT009026FG30032 worth?

The government has obligated $81,877 on HT009026FG30032.

Is contract HT009026FG30032 an order under another contract?

Yes. HT009026FG30032 is a BPA call under FA301624A0044, a blanket purchase agreement.

Was contract HT009026FG30032 competed?

The extent of competition for HT009026FG30032 was competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award